Reduction in the number of early melanomas diagnosed during the COVID‐19 pandemic: a single‐centre cohort study
2021; Wiley; Volume: 35; Issue: 11 Linguagem: Inglês
10.1111/jdv.17522
ISSN1468-3083
AutoresÉrica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa, Camilo Cárdenas, Juan C. Castro, Francisco Domı́nguez, Katherine Droppelmann, Nicolás Droppelmann, Héctor Galindo, Antônio Ponce de León, J Madrid, Montserrat Molgó, Sebastián Mondaca, Peña Montero, Pablo Uribe, Miguel Villaseca, Eugenio Vinés, Cristián Navarrete‐Dechent,
Tópico(s)COVID-19 and healthcare impacts
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 35, Issue 11 p. e735-e737 Letter To The Editor Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study E. Koch, E. Koch Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorF. Villanueva, F. Villanueva Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorM.A. Marchetti, M.A. Marchetti Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASearch for more papers by this authorÁ. Abarzúa-Araya, Á. Abarzúa-Araya Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorC. Cárdenas, C. Cárdenas Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorJ.C. Castro, J.C. Castro Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorF. Dominguez, F. Dominguez Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Surgical Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorK. Droppelmann, K. Droppelmann Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorN. Droppelmann, N. Droppelmann Department of Surgery, Clinica Universidad de Los Andes, Santiago, ChileSearch for more papers by this authorH. Galindo, H. Galindo Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorA. León, A. León Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Surgical Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorJ. Madrid, J. Madrid Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorM. Molgó, M. Molgó Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorS. Mondaca, S. Mondaca Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorP.H. Montero, P.H. Montero Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Surgical Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorP. Uribe, P. Uribe Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorM.A. Villaseca, M.A. Villaseca Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Pathology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Pathology, Universidad de la Frontera, Temuco, ChileSearch for more papers by this authorE. Vinés, E. Vinés Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Radiation Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorC. Navarrete-Dechent, Corresponding Author C. Navarrete-Dechent [email protected] orcid.org/0000-0003-4040-3640 Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile *Correspondence: C. Navarrete-Dechent. E-mail: [email protected]Search for more papers by this author E. Koch, E. Koch Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorF. Villanueva, F. Villanueva Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorM.A. Marchetti, M.A. Marchetti Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASearch for more papers by this authorÁ. Abarzúa-Araya, Á. Abarzúa-Araya Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorC. Cárdenas, C. Cárdenas Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorJ.C. Castro, J.C. Castro Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorF. Dominguez, F. Dominguez Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Surgical Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorK. Droppelmann, K. Droppelmann Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorN. Droppelmann, N. Droppelmann Department of Surgery, Clinica Universidad de Los Andes, Santiago, ChileSearch for more papers by this authorH. Galindo, H. Galindo Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorA. León, A. León Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Surgical Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorJ. Madrid, J. Madrid Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorM. Molgó, M. Molgó Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorS. Mondaca, S. Mondaca Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorP.H. Montero, P.H. Montero Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Surgical Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorP. Uribe, P. Uribe Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorM.A. Villaseca, M.A. Villaseca Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Pathology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Pathology, Universidad de la Frontera, Temuco, ChileSearch for more papers by this authorE. Vinés, E. Vinés Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Radiation Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, ChileSearch for more papers by this authorC. Navarrete-Dechent, Corresponding Author C. Navarrete-Dechent [email protected] orcid.org/0000-0003-4040-3640 Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile *Correspondence: C. Navarrete-Dechent. E-mail: [email protected]Search for more papers by this author First published: 14 July 2021 https://doi.org/10.1111/jdv.17522Citations: 12 Erica Koch and Francisco Villanueva Shared first authorship. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Breitbart EW, Waldmann A, Nolte S et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201–211. 10.1016/j.jaad.2010.11.016 PubMedWeb of Science®Google Scholar 2Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199–6206. 10.1200/JCO.2009.23.4799 PubMedWeb of Science®Google Scholar 3Marson JW, Maner BS, Harding TP et al. The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers. J Am Acad Dermatol 2021; 84: 1100–1103. 10.1016/j.jaad.2020.12.065 CASPubMedWeb of Science®Google Scholar 4Lallas A, Kyrgidis A, Manoli SM et al. Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: data from an institutional registry. J Am Acad Dermatol 2021. In press. https://doi.org/10.1016/j.jaad.2021.05.021 10.1016/j.jaad.2021.05.021 Web of Science®Google Scholar 5Tejera-Vaquerizo A, Nagore E. Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model. J Eur Acad Dermatol Venereol 2020; 34: e351–e353. 10.1111/jdv.16555 PubMedWeb of Science®Google Scholar 6Force USPST, Bibbins-Domingo K, Grossman DC et al. Screening for skin cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016; 316: 429–435. 10.1001/jama.2016.8465 PubMedWeb of Science®Google Scholar Citing Literature Volume35, Issue11November 2021Pages e735-e737 This article also appears in:JEADV COVID-19 Articles ReferencesRelatedInformation
Referência(s)